Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Can Chemring profit play catch-up after slow start to the year?

AJ Bell is an easy to use, award-winning platform Open an account
We've accounts to suit every investing need, and free guides and special offers to help you get the most from them.
You can get a few handy suggestions, or even get our experts to do the hard work for you – by picking one of our simple investment ideas.
All the resources you need to choose your shares, from market data to the latest investment news and analysis.
Funds offer an easier way to build your portfolio – we’ve got everything you need to choose the right one.
Starting to save for a pension, approaching retirement, or after an explainer on pension jargon? We can help.
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Military equipment supplier Chemring (CHG) would seem to be well placed considering the recent escalation of geopolitical tensions and conflicts which have lifted sector peers.
However, the shares have fallen sharply during the last quarter of 2024. Investors are seemingly nervous about a back-loaded fiscal 2024 (to 31 October) after a particularly harsh winter in early 2024 put the freeze on some of its manufacturing.
October’s trading update did little to quell those fears and it means the stock is up just 3% this year, excluding dividends, hardly anything to write home about.
The company flagged at the time consensus adjusted operating profit forecasts in the range of £70.8 million to £73.6 million, and judging by Berenberg’s apparent narrowing of its own estimate from £73 million in June to £71 million in October, perhaps investors should anticipate something towards the lower end of that range.
That said, there’s been plenty of contract progress, both new orders and renewals, while Chemring is mulling expansion of its operations in Norway, with a seemingly supportive government environment out there. News on this, and the outlook, will likely dictate how the shares react to full-year results, due 17 December.
FULL-YEAR RESULTS
17 Dec: Chemring
18 Dec: IntegraFin
FIRST-HALF RESULTS
19 Dec: FIH Group
TRADING ANNOUNCEMENTS
17 Dec: Vivendum
19 Dec: Time Finance
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
The value of your investments can go down as well as up and you may get back less than you originally invested. We don't offer advice, so it's important you understand the risks, if you're unsure please consult a suitably qualified financial adviser. Tax treatment depends on your individual circumstances and rules may change. Past performance is not a guide to future performance and some investments need to be held for the long term.